Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DBPR108 (Prusogliptin) in Type 2 Diabetes Mellitus
NCT04124484Phase 2Completed
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Oct 2017
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prusogliptin in type 2 diabetes mellitus (T2DM), sponsored by CSPC ZhongQi Pharmaceutical Technology. Started Oct 2017; status: completed.
02
Drugs
prusogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04124484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04124484.